Sotera Health (NYSE:SHC) Price Target Cut to $8.00 by Analysts at The Goldman Sachs Group

Sotera Health (NYSE:SHCGet Rating) had its target price lowered by The Goldman Sachs Group from $9.00 to $8.00 in a report published on Wednesday morning, Benzinga reports. The Goldman Sachs Group currently has a neutral rating on the stock.

A number of other equities analysts have also recently issued reports on the stock. TheStreet cut shares of Sotera Health from a c- rating to a d rating in a research report on Monday, September 19th. Royal Bank of Canada cut their price objective on shares of Sotera Health from $25.00 to $8.00 and set an outperform rating on the stock in a research report on Thursday, November 3rd. Barclays cut shares of Sotera Health from an equal weight rating to an underweight rating and cut their price objective for the stock from $7.00 to $6.00 in a research report on Tuesday, November 15th. JPMorgan Chase & Co. cut their price objective on shares of Sotera Health from $9.00 to $6.00 and set an underweight rating on the stock in a research report on Thursday, November 3rd. Finally, Citigroup cut shares of Sotera Health from a buy rating to a neutral rating and cut their price objective for the stock from $25.00 to $9.00 in a research report on Wednesday, October 5th. Two analysts have rated the stock with a sell rating, four have given a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of Hold and a consensus price target of $15.89.

Sotera Health Stock Performance

Shares of Sotera Health stock opened at $8.25 on Wednesday. The company has a market cap of $2.33 billion, a P/E ratio of 18.75 and a beta of 1.27. The business has a 50-day moving average price of $7.46 and a two-hundred day moving average price of $15.19. The company has a current ratio of 3.00, a quick ratio of 2.74 and a debt-to-equity ratio of 2.97. Sotera Health has a 1-year low of $5.78 and a 1-year high of $24.90.

Hedge Funds Weigh In On Sotera Health

Several large investors have recently added to or reduced their stakes in SHC. Victory Capital Management Inc. lifted its position in Sotera Health by 5.5% in the 1st quarter. Victory Capital Management Inc. now owns 2,653,434 shares of the company’s stock valued at $57,454,000 after acquiring an additional 138,909 shares in the last quarter. Russell Investments Group Ltd. increased its stake in Sotera Health by 510.0% in the 1st quarter. Russell Investments Group Ltd. now owns 73,704 shares of the company’s stock valued at $1,596,000 after buying an additional 61,621 shares during the last quarter. New York State Common Retirement Fund increased its stake in Sotera Health by 7.9% in the 1st quarter. New York State Common Retirement Fund now owns 151,959 shares of the company’s stock valued at $3,291,000 after buying an additional 11,174 shares during the last quarter. Teacher Retirement System of Texas increased its stake in Sotera Health by 6.0% in the 1st quarter. Teacher Retirement System of Texas now owns 17,409 shares of the company’s stock valued at $377,000 after buying an additional 993 shares during the last quarter. Finally, Waratah Capital Advisors Ltd. purchased a new stake in Sotera Health in the 1st quarter valued at about $1,001,000. Institutional investors own 88.38% of the company’s stock.

Sotera Health Company Profile

(Get Rating)

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.

Further Reading

Analyst Recommendations for Sotera Health (NYSE:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.